ArticleAntimicrobial agents and chemotherapy2012

Targeting the substrate preference of a type I nitroreductase to develop antitrypanosomal quinone-based prodrugs.

Belinda S Hall et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.